abrdn Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
abrdn Investment Management's BMY Position: Q2 2017 in Review
abrdn Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2017, closing a stake of 1,061,139 shares — an estimated $57.7M sold.
abrdn Investment Management first reported a position in BMY in Q2 2013 and held it in 16 quarters. The position peaked at $262M in Q2 2015. 1,595 funds tracked by Wall St. Rank hold BMY as of Q2 2017.
- abrdn Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2017 after selling out during the quarter.
- abrdn Investment Management sold 1,061,139 Bristol-Myers Squibb shares in Q2 2017, an estimated $57.7M.
- abrdn Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 16 quarters.
- abrdn Investment Management's Bristol-Myers Squibb position peaked at $262M in Q2 2015.
- 1,595 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.
Based on abrdn Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.